|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6950 AUD | 0.00% |
|
-2.11% | -5.44% |
| 20/05 | Monash IVF appoints Fleur Cattrall as inaugural Chief Medical Officer | RE |
| 20/05 | Monash IVF Group Appoints Chief Medical Officer | MT |
Company Valuation: Monash IVF Group Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 331.2 | 366.3 | 446.1 | 500.7 | 274.7 | 270.8 | - | - |
| Change | - | 10.59% | 21.81% | 12.23% | -45.14% | -1.42% | - | - |
| Enterprise Value (EV) 1 | 324.1 | 368.4 | 477.1 | 549.3 | 364.3 | 355.2 | 343.8 | 334 |
| Change | - | 13.66% | 29.53% | 15.14% | -33.69% | -2.49% | -3.21% | -2.86% |
| P/E ratio | - | 20x | 20.4x | -75.6x | 11x | 16.5x | 13.9x | 11.9x |
| PBR | 1.24x | 1.37x | 1.63x | 2.07x | 1.12x | 1.05x | 1.01x | 0.98x |
| PEG | - | - | 1.1x | 1x | -0x | -0.5x | 0.8x | 0.7x |
| Capitalization / Revenue | 1.8x | 1.9x | 2.09x | 1.96x | 1.01x | 1.01x | 0.98x | 0.94x |
| EV / Revenue | 1.77x | 1.92x | 2.23x | 2.15x | 1.34x | 1.33x | 1.24x | 1.16x |
| EV / EBITDA | 6.79x | 7.65x | 8.93x | 8.75x | 5.49x | 6.01x | 5.5x | 5.05x |
| EV / EBIT | 9.3x | 11x | 12.5x | 12.4x | 8.48x | 10.2x | 9.32x | 8.3x |
| EV / FCF | - | 22.1x | - | 17.8x | -239x | 14.1x | 10.3x | 9.29x |
| FCF Yield | - | 4.53% | - | 5.62% | -0.42% | 7.1% | 9.73% | 10.8% |
| Dividend per Share 2 | 0.042 | 0.044 | 0.044 | 0.05 | - | 0.0205 | 0.0336 | 0.0387 |
| Rate of return | 4.94% | 4.68% | 3.84% | 3.89% | - | 2.95% | 4.84% | 5.56% |
| EPS 2 | - | 0.047 | 0.056 | -0.017 | 0.064 | 0.0422 | 0.0499 | 0.0582 |
| Distribution rate | - | 93.6% | 78.6% | -294% | - | 48.6% | 67.4% | 66.4% |
| Net sales 1 | 183.6 | 192.3 | 213.6 | 255 | 271.9 | 267 | 276.7 | 286.8 |
| EBITDA 1 | 47.75 | 48.14 | 53.43 | 62.81 | 66.34 | 59.08 | 62.5 | 66.16 |
| EBIT 1 | 34.86 | 33.36 | 38.09 | 44.23 | 42.97 | 34.8 | 36.89 | 40.22 |
| Net income 1 | 25.15 | 18.41 | 21.84 | -5.949 | 25.01 | 16.51 | 19.98 | 22.54 |
| Net Debt 1 | -7.1 | 2.1 | 31 | 48.67 | 89.57 | 84.39 | 72.98 | 63.17 |
| Reference price 2 | 0.8500 | 0.9400 | 1.1450 | 1.2850 | 0.7050 | 0.6950 | 0.6950 | 0.6950 |
| Nbr of stocks (in thousands) | 3,89,635 | 3,89,635 | 3,89,635 | 3,89,635 | 3,89,635 | 3,89,635 | - | - |
| Announcement Date | 23/08/21 | 25/08/22 | 21/08/23 | 21/08/24 | 21/08/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.48x | 1.33x | 6.01x | 2.95% | 19Cr | ||
| 15.44x | 0.44x | 9.42x | 2.75% | 12TCr | ||
| 12.32x | 1.64x | 8.1x | 0.83% | 8.26TCr | ||
| 11.13x | 1.33x | 8.03x | 3.05% | 2.42TCr | ||
| 20.79x | 2.29x | 11.55x | 1.6% | 2.22TCr | ||
| 29.24x | 5.32x | 22.3x | 2.42% | 2.01TCr | ||
| 14.59x | 1.38x | 7.04x | 4.81% | 1.4TCr | ||
| 6.43x | 1.11x | 5.22x | -.--% | 1.4TCr | ||
| 13.11x | 1.64x | 7.89x | 0.87% | 1.23TCr | ||
| 12.53x | 0.98x | 5.49x | 3.63% | 1.18TCr | ||
| Average | 15.21x | 1.75x | 9.11x | 2.29% | 3.24TCr | |
| Weighted average by Cap. | 14.92x | 1.38x | 9.44x | 2.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MVF Stock
- Valuation Monash IVF Group Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















